Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight

Core Insights - Inspire Medical Systems, Inc. is participating in the Wells Fargo 2025 MedTech Innovation Spotlight on June 13, 2025 [1][2] - The company specializes in minimally invasive solutions for obstructive sleep apnea, with its proprietary Inspire therapy being the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology for this condition [3] Company Overview - Inspire Medical Systems focuses on the development and commercialization of innovative solutions for patients suffering from obstructive sleep apnea [3] - The Inspire therapy offers a safe and effective treatment option for moderate to severe obstructive sleep apnea [3] Presentation Details - The presentation by Inspire is scheduled for 12:00 p.m. Eastern Time and will be accessible via a live webcast [2] - A replay of the presentation will be available for two weeks in the Event Archive section of Inspire's Investor website [2]